Aberdeen Group plc

Holdings History for Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)

Symbol: IMVT on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.05%	+0.01%	$30,100,381	1,184,122	+202,318	+21%	$25.42	Q4 2025
30 Sep 2025	0.03%	+0%	$15,826,680	981,804	+137,099	+16%	$16.12	Q3 2025
30 Jun 2025	0.02%	+0%	$13,515,280	844,705	+25,228	+3.1%	$16.00	Q2 2025
31 Mar 2025	0.03%	+0.01%	$14,004,862	819,477	+287,367		$17.09	Q1 2025
31 Dec 2024	0.02%	+0%	$13,180,365	532,110	+53,353	+11%	$24.77	Q4 2024
30 Sep 2024	0.03%	+0%	$13,649,362	478,757	+78,035	+19%	$28.51	Q3 2024
30 Jun 2024	0.02%	+0.01%	$10,579,061	400,722	+213,086	+114%	$26.40	Q2 2024
31 Mar 2024	0.01%	-0.01%	$6,062,519	187,636	-140,070	-43%	$32.31	Q1 2024
31 Dec 2023	0.03%	+0.03%	$13,806,254	327,706	+327,706	NEW	$42.13	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.